Last reviewed · How we verify

NCT04499807

Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)

Terminated NA Last updated 10 March 2023
What this trial tests

NA trial testing AFib detection with wearable smart watch in Atrial Fibrillation in 16 participants. Terminated before completion.

Timeline
6 January 2021
Primary endpoint
16 March 2021
16 March 2021

Quick facts

Lead sponsorKansas City Heart Rhythm Research Foundation
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment16
Start date6 January 2021
Primary completion16 March 2021
Estimated completion16 March 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kansas City Heart Rhythm Research Foundation

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is an attempt to see the reliability of the Wearable Smart Watch in identifying atrial fibrillation and other arrhythmias compared to the data detected from ILRs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Kansas City Heart Rhythm Research Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499807.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing